Wordt geladen...
Identification of a New Scaffold for Hsp90 C-Terminal Inhibition
[Image: see text] Inhibition of Hsp90 C-terminal function is an advantageous therapeutic paradigm for the treatment of cancer. Currently, the majority of Hsp90 C-terminal inhibitors are derived from novobiocin, a natural product traditionally used as an antibiotic. Assisted by molecular docking stud...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Chemical
Society
2013
|
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4027776/ https://ncbi.nlm.nih.gov/pubmed/24900777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml400404s |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|